Literature DB >> 17409153

Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein.

Weifan Gao1, Jianming Hu.   

Abstract

Hepatitis B virus (HBV) contains a small, partially double-stranded, relaxed circular (RC) DNA genome. RC DNA needs to be converted to covalently closed circular (CCC) DNA, which serves as the template for all viral RNA transcription. As a first step toward understanding how CCC DNA is formed, we analyzed the viral and host factors that may be involved in CCC DNA formation, using transient and stable DNA transfections of HBV and the related avian hepadnavirus, duck hepatitis B virus (DHBV). Our results show that HBV CCC DNA formed in hepatoma cells was derived predominantly from RC DNA with a precise junction sequence. In contrast to that of DHBV, HBV CCC DNA formation in cultured cells was accompanied by the accumulation of a RC DNA species from which the covalently attached viral reverse transcriptase (RT) protein was removed (protein-free or PF-RC DNA). Furthermore, whereas envelope deficiency led to increased CCC DNA formation in DHBV, it resulted mainly in increased PF-RC, but not CCC, DNA in HBV, suggesting that the envelope protein(s) may negatively regulate a step in CCC DNA formation that precedes deproteination in both HBV and DHBV. Interestingly, PF-RC DNA, in contrast to RT-linked RC DNA, contained, almost exclusively, mature plus-strand DNA, suggesting that the RT protein was removed preferentially from mature RC DNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409153      PMCID: PMC1900077          DOI: 10.1128/JVI.02721-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.

Authors:  W E Delaney; T G Miller; H C Isom
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Viral clearance without destruction of infected cells during acute HBV infection.

Authors:  L G Guidotti; R Rochford; J Chung; M Shapiro; R Purcell; F V Chisari
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

3.  The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis.

Authors:  G H Wang; C Seeger
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

Review 4.  Why are hepadnaviruses DNA and not RNA viruses?

Authors:  C Seeger; J Hu
Journal:  Trends Microbiol       Date:  1997-11       Impact factor: 17.079

5.  Lamivudine therapy of WHV-infected woodchucks.

Authors:  W S Mason; J Cullen; G Moraleda; J Saputelli; C E Aldrich; D S Miller; B Tennant; L Frick; D Averett; L D Condreay; A R Jilbert
Journal:  Virology       Date:  1998-05-25       Impact factor: 3.616

6.  Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.

Authors:  W Yang; J Summers
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

7.  Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.

Authors:  W E Delaney; H C Isom
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

8.  Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

9.  Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements.

Authors:  D D Loeb; R C Hirsch; D Ganem
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

10.  Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.

Authors:  E V Genovesi; L Lamb; I Medina; D Taylor; M Seifer; S Innaimo; R J Colonno; D N Standring; J M Clark
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.938

View more
  105 in total

1.  Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.

Authors:  L Luckenbaugh; K M Kitrinos; W E Delaney; J Hu
Journal:  J Viral Hepat       Date:  2014-11-14       Impact factor: 3.728

2.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

3.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 4.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

5.  Maturation-associated destabilization of hepatitis B virus nucleocapsid.

Authors:  Xiuji Cui; Laurie Ludgate; Xiaojun Ning; Jianming Hu
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

6.  In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.

Authors:  Xiaonan Zhang; Wei Lu; Ye Zheng; Weixia Wang; Lu Bai; Liang Chen; Yanling Feng; Zhanqing Zhang; Zhenghong Yuan
Journal:  J Clin Invest       Date:  2016-02-22       Impact factor: 14.808

7.  Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.

Authors:  Zekun Wang; Jinjing Ni; Jianhua Li; Bisheng Shi; Yang Xu; Zhenghong Yuan
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

Review 8.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors:  Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

10.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.